NCT03936192 - A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study | Biotech Hunter

Timeline

Start Date

January 31, 2019

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions

Knee Osteoarthritis

Interventions

DRUG

glucosamine sulphate 1500mg and meloxicam 15mg

glucosamine sulphate 1500mg plus meloxicam 15mg, manufactured by Eurofarma Laboratories S.A., administered once a day for 12 weeks.

DRUG

Glucosamine sulfate 1500mg and chondroitin sulfate 1200mg

Glucosamine sulfate 1500mg and chondroitin sulfate 1200mg, manufactured by Zodiac Pharmaceutical Products S.A. (Condroflex®)

DRUG

Placebos

Placebo administered once daily for 12 weeks.